Retrophin Provides Corporate Update and 2020 Outlook

    NEXT STORY
    KaNDy Therapeutics Announces Positive Phase 2b Data in Post-Menopausal Women with its Lead Non-Hormonal Product NT-814
    PREV STORY
    Emergent BioSolutions Receives EMA Agreement for Proposed Development Path of Investigational Chikungunya VLP Vaccine Candidate
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Montage International Selects Modernized Primary Care Provider One Medical to Deliver 24/7 Digital Health Services to Its Guests and Associates

    author_avatar
    NASDAQ Market News

    Helsinn Advanced Synthesis wins across all categories at the 2018 CMO Leadership Awards

    Helsinn Advanced Synthesis wins across all categories at the 2018 CMO Leadership Awards For ...

    author_avatar
    NASDAQ Market News

    G1 Therapeutics to Present at 36th Annual J.P. Morgan Healthcare Conference

    RESEARCH TRIANGLE PARK, N.C., Jan. 02, 2018 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq:GTHX), ...

    author_avatar
    NASDAQ Market News